Home sunrisefpau Hims & Hers abandons copycat weight-loss drug in face of FDA probe Hims & Hers abandons copycat weight-loss drug in face of FDA probe Author - Financial Adviser Melbourne February 07, 2026 0 Novo Nordisk had accused the telehealth company of breaching its patent on Wegovy International homepage Tags sunrisefpau Facebook Twitter Whatsapp Newer Older
